A Phase 4 interventional study of Topical Cyclosporine in Pterygia, sponsored by Innovative Medical. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2007-02-13.
Sponsored by Innovative Medical · Phase 4 and Interventional
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Pterygium with a site in United States — none open to participants now, 1 under way, 1 of them phase 3. Pterygium · United States.
Among the 12 studies in Pterygium with a site in United States, this one is one of 4 in phase 4, and was the 1st registered.
109 studies on the registry are indexed under Pterygium; 9 are open to participants now.
Browse Pterygium studies →None of the 12 studies in Pterygium with a site in United States is open now. The open studies under Pterygium, anywhere →
Of the 3 Pterygium studies recruiting now, 2 set no upper age limit and 1 stops at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked.
By drug class, each counting the studies that test any of its medicines:
Median enrollment 31 across the 11 interventional studies. Of the 11 that completed or were terminated, 5 (45%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 12 have an industry lead sponsor. The 10 most frequent:
Innovative Medical is the lead sponsor of 51 studies on the registry; none are open to participants now.
Innovative Medical has 1 study filed under Pterygium — fewer than ten, so there is no comparison to draw.
1 of the studies in Pterygium with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05456425Phase 3Cloudbreak Therapeutics, LLCA Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Pterygium with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.
Inclusion Criteria:
This study is completed, as verified in Feb 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Cyclosporine